Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
As of Jan. 5, 2024, four stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.
Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, with the index moving to the "Greed" zone on Thursday.
U.S. stocks closed mixed on Thursday, with the Nasdaq Composite recording losses for a fifth straight session. The index has fallen around 4% since the Dec. 27 close, after surging around 43% in 2023.
The Greenbrier Companies, Inc. (NYSE: GBX) is projected to release financial results for the first quarter ended Nov. 30, 2023, before the opening bell on Jan. 5, 2023.
Franklin Covey Company (NYSE: FC) shares are trading lower in Thursday's after-hours session. The stock initially rose on news of the company's first-quarter earnings results but soon tumbled lower.